{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T08:57:25Z","timestamp":1768899445265,"version":"3.49.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,12,9]],"date-time":"2019-12-09T00:00:00Z","timestamp":1575849600000},"content-version":"vor","delay-in-days":8,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>There is widespread concern across the clinical and research communities that clinical trials, powered for patient-reported outcomes, testing new surgical procedures are often expensive and time-consuming, particularly when the new intervention is shown to be no better than the standard. Conventional (non-adaptive) randomised controlled trials (RCTs) are perceived as being particularly inefficient in this setting. Therefore, we have developed an adaptive group sequential design that allows early endpoints to inform decision making and show, through simulations and a worked example, that these designs are feasible and often preferable to conventional non-adaptive designs. The methodology is motivated by an ongoing clinical trial investigating a saline-filled balloon, inserted above the main joint of the shoulder at the end of arthroscopic debridement, for treatment of tears of rotor cuff tendons. This research question and setting is typical of many studies undertaken to assess new surgical procedures.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Test statistics are presented based on the setting of two early outcomes, and methods for estimation of sequential stopping boundaries are described. A framework for the implementation of simulations to evaluate design characteristics is also described.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Simulations show that designs with one, two and three early looks are feasible and, with appropriately chosen futility stopping boundaries, have appealing design characteristics. A number of possible design options are described that have good power and a high probability of stopping for futility if there is no evidence of a treatment effect at early looks. A worked example, with code in R, provides a practical demonstration of how the design might work in a real study.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>In summary, we show that adaptive designs are feasible and could work in practice. We describe the operating characteristics of the designs and provide guidelines for appropriate values for the stopping boundaries for the START:REACTS (Sub-acromial spacer for Tears Affecting Rotator cuff Tendons: a Randomised, Efficient, Adaptive Clinical Trial in Surgery) study.<\/jats:p><\/jats:sec><jats:sec><jats:title>Trial registration<\/jats:title><jats:p>ISRCTN Registry, ISRCTN17825590. Registered on 5 March 2018.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s13063-019-3708-6","type":"journal-article","created":{"date-parts":[[2019,12,9]],"date-time":"2019-12-09T15:03:13Z","timestamp":1575903793000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["An adaptive two-arm clinical trial using early endpoints to inform decision making: design for a study of sub-acromial spacers for repair of rotator cuff tendon tears"],"prefix":"10.1186","volume":"20","author":[{"given":"Nick","family":"Parsons","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nigel","family":"Stallard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen","family":"Parsons","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip","family":"Wells","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Underwood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Mason","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Metcalfe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,12,9]]},"reference":[{"key":"3708_CR1","doi-asserted-by":"publisher","first-page":"3012","DOI":"10.1136\/bmj.f3012","volume":"346","author":"P McCulloch","year":"2013","unstructured":"McCulloch P, Cook JA, Altman DG, Heneghan C, Diener MK, Group I. Ideal framework for surgical innovation 1: the idea and development stages. BMJ. 2013; 346:3012.","journal-title":"BMJ"},{"key":"3708_CR2","doi-asserted-by":"publisher","first-page":"3011","DOI":"10.1136\/bmj.f3011","volume":"346","author":"PL Ergina","year":"2013","unstructured":"Ergina PL, Barkun JS, McCulloch P, Cook JA, Altman DG, Group I. Ideal framework for surgical innovation 2: observational studies in the exploration and assessment stages. BMJ. 2013; 346:3011.","journal-title":"BMJ"},{"key":"3708_CR3","doi-asserted-by":"publisher","first-page":"2820","DOI":"10.1136\/bmj.f2820","volume":"346","author":"JA Cook","year":"2013","unstructured":"Cook JA, McCulloch P, Blazeby JM, Beard DJ, Marinac-Dabic D, Sedrakyan A, Group I. Ideal framework for surgical innovation 3: randomised controlled trials in the assessment stage and evaluations in the long term study stage. BMJ. 2013; 346:2820.","journal-title":"BMJ"},{"issue":"3","key":"3708_CR4","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1002\/sim.6472","volume":"35","author":"P Bauer","year":"2016","unstructured":"Bauer P, Bretz F, Dragalin V, Konig F, Wassmer G. Twenty-five years of confirmatory adaptive designs: opportunities and pitfalls. Stat Med. 2016; 35(3):325\u201347.","journal-title":"Stat Med"},{"issue":"1","key":"3708_CR5","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s12916-018-1017-7","volume":"16","author":"P Pallmann","year":"2018","unstructured":"Pallmann P, Bedding AW, Choodari-Oskooei B, Dimairo M, Flight L, Hampson LV, Holmes J, Mander AP, Odondi L, Sydes MR, Villar SS, Wason JMS, Weir CJ, Wheeler GM, Yap C, Jaki T. Adaptive designs in clinical trials: why use them, and how to run and report them. BMC Med. 2018; 16(1):29.","journal-title":"BMC Med"},{"key":"3708_CR6","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/1750-1172-6-79","volume":"6","author":"SC Chow","year":"2011","unstructured":"Chow SC, Corey R. Benefits, challenges and obstacles of adaptive clinical trial designs. Orphanet J Rare Dis. 2011; 6:79.","journal-title":"Orphanet J Rare Dis"},{"key":"3708_CR7","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/1745-6215-13-145","volume":"13","author":"JA Kairalla","year":"2012","unstructured":"Kairalla JA, Coffey CS, Thomann MA, Muller KE. Adaptive trial designs: a review of barriers and opportunities. Trials. 2012; 13:145.","journal-title":"Trials"},{"issue":"8","key":"3708_CR8","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/S1359-6446(04)03023-5","volume":"9","author":"P Bauer","year":"2004","unstructured":"Bauer P, Brannath W. The advantages and disadvantages of adaptive designs for clinical trials. Drug Discov Today. 2004; 9(8):351\u20137.","journal-title":"Drug Discov Today"},{"issue":"9","key":"3708_CR9","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1002\/sim.3863","volume":"29","author":"N Stallard","year":"2010","unstructured":"Stallard N. A confirmatory seamless phase II\/III clinical trial design incorporating short-term endpoint information. Stat Med. 2010; 29(9):959\u201371.","journal-title":"Stat Med"},{"key":"3708_CR10","unstructured":"National Institute for Health Research. https:\/\/www.nihr.ac.uk\/."},{"issue":"11","key":"3708_CR11","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1002\/sim.1311","volume":"22","author":"S Galbraith","year":"2003","unstructured":"Galbraith S, Marschner IC. Interim analysis of continuous long-term endpoints in clinical trials with longitudinal outcomes. Stat Med. 2003; 22(11):1787\u2013805.","journal-title":"Stat Med"},{"issue":"1","key":"3708_CR12","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1302\/0301-620X.96B1.32168","volume":"96","author":"J Kukkonen","year":"2014","unstructured":"Kukkonen J, Joukainen A, Lehtinen J, Mattila KT, Tuominen EK, Kauko T, Aarimaa V. Treatment of non-traumatic rotator cuff tears: a randomised controlled trial with one-year clinical results. Bone Joint J. 2014; 96(1):75\u201381.","journal-title":"Bone Joint J"},{"issue":"4","key":"3708_CR13","doi-asserted-by":"publisher","first-page":"010412","DOI":"10.1136\/bmjopen-2015-010412","volume":"6","author":"A Rangan","year":"2016","unstructured":"Rangan A, Upadhaya S, Regan S, Toye F, Rees JL. Research priorities for shoulder surgery: results of the 2015 James Lind Alliance patient and clinician priority setting partnership. BMJ Open. 2016; 6(4):010412.","journal-title":"BMJ Open"},{"key":"3708_CR14","unstructured":"OrthoSpace Massive Rotator Cuff Repair. http:\/\/orthospace.co.il\/. Accessed 17 Oct 2019."},{"issue":"4","key":"3708_CR15","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1177\/0363546508328115","volume":"37","author":"RT Burks","year":"2009","unstructured":"Burks RT, Crim J, Brown N, Fink B, Greis PE. A prospective randomized clinical trial comparing arthroscopic single- and double-row rotator cuff repair: magnetic resonance imaging and early clinical evaluation. Am J Sports Med. 2009; 37(4):674\u201382.","journal-title":"Am J Sports Med"},{"key":"3708_CR16","unstructured":"START:REACTS. https:\/\/warwick.ac.uk\/fac\/sci\/med\/research\/ctu\/trials\/startreacts\/. Accessed 17 Oct 2019."},{"key":"3708_CR17","unstructured":"ISRCTN Registry. http:\/\/www.isrctn.com\/ISRCTN17825590. Accessed 17 Oct 2019."},{"key":"3708_CR18","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1097\/00003086-198701000-00023","volume":"214","author":"C Constant","year":"1987","unstructured":"Constant C, Murley A. A clinical method of functional assessment of the shoulder. Clin Orthop Relat Res. 1987; 214:160\u20134.","journal-title":"Clin Orthop Relat Res"},{"issue":"2","key":"3708_CR19","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.jse.2007.06.022","volume":"17","author":"C Constant","year":"2008","unstructured":"Constant C, Gerber C, Emery R, Sojbjerg J, Gohlke F, Boileau P. A review of the Constant score: modifications and guidelines for its use. J Should Elb Surg. 2008; 17(2):355\u201361.","journal-title":"J Should Elb Surg"},{"issue":"1","key":"3708_CR20","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.jse.2009.04.008","volume":"19","author":"J Roy","year":"2010","unstructured":"Roy J, MacDermid J, Woodhouse L. A systematic review of the psychometric properties of the Constant-Murley score. J Should Elb Surg. 2010; 19(1):157\u201364.","journal-title":"J Should Elb Surg"},{"issue":"1","key":"3708_CR21","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.jse.2011.07.014","volume":"21","author":"D Blonna","year":"2012","unstructured":"Blonna D, Scelsi M, Bellato EME, Tellini A, Rossi R, Bonasia D, Castoldi F. Can we improve the reliability of the Constant-Murley score?. J Should Elb Surg. 2012; 21(1):4\u201312.","journal-title":"J Should Elb Surg"},{"issue":"4","key":"3708_CR22","first-page":"4608","volume":"60","author":"I Ban","year":"2013","unstructured":"Ban I, Troelsen A, Christiansen D, Svendsen S, Kristensen M. Standardised test protocol (Constant score) for evaluation of functionality in patients with shoulder disorders. Dan Med J. 2013; 60(4):4608.","journal-title":"Dan Med J"},{"issue":"8","key":"3708_CR23","doi-asserted-by":"publisher","first-page":"620","DOI":"10.2519\/jospt.2015.5760","volume":"45","author":"D Christiansen","year":"2015","unstructured":"Christiansen D, Frost P, Falla D, Haahr J, Frich L, Svendsen S. Responsiveness and minimal clinically important change: comparison between 2 shoulder outcome measures. J Orthop Sports Phys Ther. 2015; 45(8):620\u20135.","journal-title":"J Orthop Sports Phys Ther"},{"issue":"1","key":"3708_CR24","first-page":"1","volume":"47","author":"C Khatri","year":"2018","unstructured":"Khatri C, Ahmed I, Parsons H, Smith N, Lawrence T, Modi C, Drew S, Bhabra G, Parsons N, Underwood M, Metcalfe A. The natural history of full-thickness rotator cuff tears in randomized controlled trials: a systematic review and meta-analysis. Am J Sports Med. 2018; 47(1):1\u20131.","journal-title":"Am J Sports Med"},{"issue":"5","key":"3708_CR25","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1136\/ard.2004.021188","volume":"64","author":"J Haahra","year":"2005","unstructured":"Haahra J, Ostergaard S, Dalsgaard J, Norup K, Frost P, Lausen S, Holm E, Andersen J. Exercises versus arthroscopic decompression in patients with subacromial impingement: a randomised, controlled study in 90 cases with a one year follow up. Ann Rheum Dis. 2005; 64(5):760\u20134.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"3708_CR26","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1302\/0301-620X.92B1.22137","volume":"92","author":"S Karthikeyan","year":"2010","unstructured":"Karthikeyan S, Kwong H, Upadhyay P, Parsons N, Drew S, Griffin D. A double blind randomised controlled study comparing subacromial NSAID (tenoxicam) injection with steroid (methylprednisolone) injection in patients with subacromial impingement syndrome. J Bone Joint Surg (British). 2010; 92(1):77\u201382.","journal-title":"J Bone Joint Surg (British)"},{"issue":"3","key":"3708_CR27","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/s00590-012-0981-4","volume":"23","author":"V Senekovic","year":"2013","unstructured":"Senekovic V, Poberaj B, Kovacic L, Mikek M, Adar E, Dekel A. Prospective clinical study of a novel biodegradable sub-acromial spacer in treatment of massive irreparable rotator cuff tears. Eur J Orthop Surg Traumatol. 2013; 23(3):311\u201316.","journal-title":"Eur J Orthop Surg Traumatol"},{"key":"3708_CR28","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/0197-2456(92)90017-T","volume":"13","author":"J. Whitehead","year":"1992","unstructured":"Whitehead J.Overrunning and underrunning in sequential clinical trials. Control Clin Trials. 1992; 13:106\u201321.","journal-title":"Control Clin Trials"},{"key":"3708_CR29","volume-title":"Group sequential methods with applications to clinical trials","author":"C Jennison","year":"2000","unstructured":"Jennison C, Turnbull BW. Group sequential methods with applications to clinical trials. Boca Raton: Chapman & Hall\/CRC; 2000, p. 390."},{"key":"3708_CR30","doi-asserted-by":"crossref","unstructured":"Barnard K, Dent L, Cook A. A systematic review of models to predict recruitment to multicentre clinical trials. BMC Med Res Methodol. 2010;10(63).","DOI":"10.1186\/1471-2288-10-63"},{"key":"3708_CR31","volume-title":"R: a language and environment for statistical computing","author":"R Core Team","year":"2018","unstructured":"R Core Team. R: a language and environment for statistical computing. Vienna: R Foundation for Statistical Computing; 2018. https:\/\/www.R-project.org\/. Accessed 17 Oct 2019."},{"key":"3708_CR32","unstructured":"Anderson K. gsDesign: Group Sequential Design. 2016. R package version 3.0-1 https:\/\/CRAN.R-project.org\/package=gsDesign. Accessed 17 Oct 2019."},{"issue":"8","key":"3708_CR33","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1002\/sim.3538","volume":"28","author":"F Bretz","year":"2009","unstructured":"Bretz F, Koenig F, Brannath W, Glimm E, Posch M. Adaptive designs for confirmatory clinical trials. Stat Med. 2009; 28(8):1181\u2013217.","journal-title":"Stat Med"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-019-3708-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13063-019-3708-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-019-3708-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,8]],"date-time":"2022-10-08T00:49:42Z","timestamp":1665190182000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-019-3708-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["3708"],"URL":"https:\/\/doi.org\/10.1186\/s13063-019-3708-6","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"3 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethics approval is not applicable for this manuscript, as it describes methodological development work and uses simulated data only.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors have previously received or are currently in receipt of funding from the NIHR. MU was Chair of the NICE accreditation advisory committee until March 2017 for which he received a fee. MU is also chief investigator or co-investigator on multiple previous and current research grants from the NIHR and Arthritis Research UK, and he is a co-investigator on grants funded by the Australian National Health and Medical Research Council (NHMRC) and an NIHR Senior Investigator. MU has received travel expenses for speaking at conferences from the professional organisations hosting the conferences, and he is a director and shareholder of Clinvivo Ltd, which provides electronic data collection for health services research. MU is part of an academic partnership with Serco Ltd related to return to work initiatives, an editor of the NIHR journal series and a member of the NIHR Journal Editors Group, for which he receives a fee. The makers of the InSpace balloon, Orthospace Ltd, have had no involvement in the conception, design, conduct or analysis of this work, and have had no involvement in preparing the manuscript except to check its content for intellectual property transgressions. They are providing 50 free balloons for the trial and have provided training for surgeons in using the device, but they have no other involvement in the trial. The full independence of the trial team is clearly laid out contractually in line with standard NIHR terms.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"694"}}